Document is current
Any future updates will be listed below
-
Authors
Acharya, Sundaram https://orcid.org/0000-0001-5164-6328
Ansari, Asgar Hussain https://orcid.org/0000-0002-1172-9521
Kumar Das, Prosad https://orcid.org/0009-0008-6821-807X
Hirano, Seiichi
Aich, Meghali
Rauthan, Riya
Mahato, Sudipta
Maddileti, Savitri
Sarkar, Sajal
Kumar, Manoj
Phutela, Rhythm
Gulati, Sneha
Rahman, Abdul
Goel, Arushi
Afzal, C.
Paul, Deepanjan
Agrawal, Trupti https://orcid.org/0000-0002-2346-9958
Pulimamidi, Vinay Kumar
Jalali, Subhadra
Nishimasu, Hiroshi https://orcid.org/0000-0002-2505-1416
Mariappan, Indumathi https://orcid.org/0000-0001-7059-3030
Nureki, Osamu https://orcid.org/0000-0003-1813-7008
Maiti, Souvik
Chakraborty, Debojyoti https://orcid.org/0000-0002-2300-4333
-
Funding
Funding for this research was provided by:
Lady Tata Memorial Trust (GAP198)
DST | Science and Engineering Research Board
Department of Biotechnology, Ministry of Science and Technology
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 29 May 2024
First Online: 28 June 2024
Competing interests
: S.A., S.M., and D.C. are listed as co-inventors for US Patent titled, “Kinetically enhanced engineered FnCas9 and its uses thereof” related to the engineered FnCas9 variants described in this study. The patent applicant is the Council of Scientific and Industrial Research, New Delhi, India, and the application number is 18/049,291. The patent has been granted. The other authors declare no competing interests.
